News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Yuji Uehara: Morning immuno-chemotherapy nearly doubled survival in NSCLC
Yuji Uehara/X
Mar 3, 2025, 11:31

Yuji Uehara: Morning immuno-chemotherapy nearly doubled survival in NSCLC

Yuji Uehara, Medical Oncologist at National Cancer Center Japan, shared a post on X about a paper by Zhe Huang et al. published in eBioMedicine:

“Timing might matter in NSCLC! A bi-continental study shows morning immuno-chemotherapy (before 11:30 AM) nearly doubled survival vs afternoon dosing (33.0 vs 19.5 months). RWE from France and China – time to rethink the schedule of immunotherapy!”

“Overall survival according to time-of-day of combined immuno-chemotherapy for advanced non-small cell lung cancer: a bicentric bicontinental study”

Authors: Zhe Huang, Abdoulaye Karaboué, Liang Zeng, Yongchang Zhang, Francis Lévi et al.

Yuji Uehara: Morning immuno-chemotherapy nearly doubled survival in NSCLC

More posts featuring Yuji Uehara.

Abdoulaye Karaboué cancer Francis Lévi Liang Zeng non small cell lung cancer NSCLC OncoDaily Oncology Yongchang Zhang Yuji Uehara Zhe Huang
Special Coverage
Insight
Mar 3, 2025, 11:32
Missed Cancer Diagnoses: A Silent Crisis - The Institute of Cancer and Crisis
Insight
Mar 3, 2025, 11:31
Yuji Uehara: Morning immuno-chemotherapy nearly doubled survival in NSCLC
Blog
Mar 3, 2025, 11:30
Kristina Jankovic: ctDNA in the treatment of breast cancer - are we there yet?
Blog
Mar 3, 2025, 11:29
Nelson Dusetti: Honored to present a seminar at ONCOLille Institute on Personalized Treatment for Pancreatic Cancer
Science
Mar 3, 2025, 11:05
Michael Chuong: Contemporary radiation therapy for locally advanced pancreatic cancer
Blog
Mar 3, 2025, 10:57
Marco Donia: RNA splicing generates cancer neoantigens, beyond mutations
Science
Mar 3, 2025, 10:44
Joshua Reuss: Discordant IO response in biphasic diffuse pleural mesothelioma
Blog
Mar 3, 2025, 10:40
Cathy Eng: Strollin' for the colon in Nashville
Blog
Mar 3, 2025, 10:34
Wafaa M Rashed: Celebrating Women in STEM and Leadership
Blog
Mar 3, 2025, 10:28
Jérôme Salomon: Preparation for the 4th High Level Meeting during United Nations General Assembly
Blog
Mar 3, 2025, 10:24
ASCO's new living guideline update for Stage IV NSCLC with Driver Alterations
Blog
Mar 3, 2025, 10:19
Zoë Mullan: The latest issue of The Lancet Global Health